Patents by Inventor Gerry B. Berg

Gerry B. Berg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Augmentation of oncology immunotherapies by pterostilbene containing compositions
    Patent number: 9682047
    Abstract: Compositions and methods useful to enhancing, improving, or eliciting anti-tumor immune responses are disclosed. A pterostilbene containing composition is administered to a cancer patient at a sufficient concentration and frequency to induce de-repression of tumor targeting immune responses. The composition enhances antibody dependent cellular toxicity (ADCC) and augments efficacy of antigen specific immunotherapeutics such as trastuzumab and other monoclonal antibody therapies useful for treating cancer.
    Type: Grant
    Filed: July 7, 2016
    Date of Patent: June 20, 2017
    Assignee: Therapeutic Solutions International, Inc.
    Inventors: Timothy G. Dixon, Gerry B. Berg, Robert F. Graham, Santosh Kesari, Thomas Ichim
  • AUGMENTATION OF ONCOLOGY IMMUNOTHERAPIES BY PTEROSTILBENE CONTAINING COMPOSITIONS
    Publication number: 20160324801
    Abstract: Compositions and methods useful to enhancing, improving, or eliciting anti-tumor immune responses are disclosed. A pterostilbene containing composition is administered to a cancer patient at a sufficient concentration and frequency to induce de-repression of tumor targeting immune responses. The composition enhances antibody dependent cellular toxicity (ADCC) and augments efficacy of antigen specific immunotherapeutics such as trastuzumab and other monoclonal antibody therapies useful for treating cancer.
    Type: Application
    Filed: July 7, 2016
    Publication date: November 10, 2016
    Inventors: Timothy G. Dixon, Gerry B. Berg, Robert F. Graham, Santosh Kesari, Thomas Ichim